Analysis of the Global Infectious Disease Diagnostics Market
Analysis of the Global Infectious Disease Diagnostics Market
Molecular Methods Present Significant Opportunities
23-Sep-2014
North America
$3,950.00
Special Price $2,962.50 save 25 %
Description
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalence of these diseases and the growing demand for rapid diagnostic tests. Regional breakdowns are provided for three market segments: immunodiagnostics, molecular methods, and clinical microbiology. Regional breakdowns by disease also are provided. The base year for the study is 2013; the forecast period is from 2014 to 2018.
Table of Contents
Key Findings
Key Findings (continued)
Scope and Segmentation
Top Diseases by Region
Diseases and Available Solutions in the Global Market
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Executive Summary—3 Big Predictions
Market Background—Infectious Diseases
Disease Background—Sepsis
Disease Background—TB
Disease Background—MRSA
Disease Background—Hepatitis B and C
Disease Background—Hepatitis B and C (continued)
Disease Background—Hantavirus
Market Segmentation—Definitions
Market Segmentation
Healthcare Trends
Solutions Provided for Each Disease
New Market Opportunities
New Market Opportunities (continued)
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Market Restraints
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Revenue Forecast Discussion
Percent Revenue Forecast by Region
Revenue Forecast by Region
Percent Revenue Forecast by Segment
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
Segment Lifecycle Analysis
Competitive Environment
Marketed Product Analysis—TB
Marketed Product Analysis—TB (continued)
Marketed Product Analysis—Sepsis
Marketed Product Analysis—MRSA
Marketed Product Analysis—Hepatitis B/C
Marketed Product Analysis—Hepatitis B/C (continued)
Top Competitors
Top Competitors (continued)
Top Competitors (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Disease
Revenue Forecast Discussion
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
US—Market Analysis
PESTLE Analysis
Market Impact of Top Trends
US—Market Share by Tier
US—Tier Analysis
US—Tier Analysis (continued)
US—Tier Analysis (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Disease
Revenue Forecast Discussion
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
PESTLE Analysis
Market Impact of Top Trends
Western Europe—Market Analysis
Western Europe—Market Share by Tier
Western Europe—Tier Analysis
Western Europe—Tier Analysis (continued)
Western Europe—Tier Analysis (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Revenue Forecast by Segment Discussion (continued)
Revenue Forecast by Segment Discussion (continued)
PESTLE Analysis
Market Impact of Top Trends
APAC & ROW—Market Analysis
APAC & ROW—Market Share by Tier
APAC & ROW—Tier Analysis
APAC & ROW—Tier Analysis
Reagena
Nanomix
Anagnostics GmbH
The Last Word—3 Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
Drivers Explained
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
List of Other Companies—United States
List of Other Companies—Western Europe
List of Other Companies—APAC and ROW
Associated Multimedia
Associated Multimedia (continued)
Market Engineering Methodology
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
Related Research
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Aish Vivekanadan |
WIP Number | NE02-01-00-00-00 |
Is Prebook | No |